INIS
patients
100%
indonesia
66%
hospitals
59%
drugs
49%
antibiotics
34%
levels
24%
data
21%
diabetes mellitus
18%
evaluation
17%
risks
16%
interventions
16%
comparative evaluations
16%
cancer
15%
therapy
14%
doses
13%
covid-19
12%
values
12%
hemoglobin
11%
blood
11%
iron
11%
surgery
11%
control
10%
cities
10%
hypertension
10%
side effects
9%
implementation
9%
communities
9%
design
9%
synthesis
8%
protons
8%
pumps
8%
structure-activity relationships
8%
benzoates
8%
diseases
8%
women
8%
administration
8%
management
7%
boron chlorides
7%
medical records
6%
cost
6%
guidelines
6%
prophylaxis
6%
in vitro
6%
europe
6%
pharmaceuticals
6%
units
6%
insulin
6%
kidneys
6%
children
5%
sampling
5%
Keyphrases
Indonesia
62%
Antibiotics
24%
Drug-related Problems
22%
General Hospital
17%
Pharmacist
15%
Depok
15%
Antibiotic Use
15%
Pada
14%
Indonesian
12%
Type 2 Diabetes Mellitus Patients
12%
Jakarta
12%
Eugenol
12%
Medical Records
11%
Primary Care
10%
Depok City
9%
Hemoglobin A1c (HbA1c)
9%
Hypertension
8%
Proton Pump Inhibitors
8%
Patients with Hypertension
8%
Metformin
7%
Type 2 Diabetes Mellitus (T2DM)
7%
Counseling
7%
IC50
7%
National Formulary
7%
Antibiotic Prescription
7%
COVID-19 Patients
6%
Drug Use
6%
Geriatric Patients
6%
Clinical Characteristics
6%
Interprofessional Collaboration
6%
Community Health Centers
6%
Self-medication
6%
Primary Health Center
6%
MMAS-8
5%
Defined Daily Dose
5%
Self-medication with Antibiotics
5%
Benzoate Derivatives
5%
Eugenyl Benzoate
5%
Bcl-2 Inhibitor
5%
In Silico Study
5%
AIDS/HIV
5%
Colorectal Cancer
5%
Bekasi
5%
Cytotoxic Activity
5%
Primary Healthcare Centers
5%
Molecular Docking
5%
In Vitro Activity
5%
Czech Republic
5%
Pregnant Women
5%
Iron Supplementation
5%
Pharmacology, Toxicology and Pharmaceutical Science
Antibiotics
37%
Cross-Sectional Study
27%
Non Insulin Dependent Diabetes Mellitus
16%
Eugenol
12%
Pharmaceutical Care
11%
Defined Daily Dose
11%
Diseases
10%
Adverse Drug Reaction
9%
Diabetes Mellitus
9%
Metformin
8%
1,1 Dichloro 2,2 Bis(4 Chlorophenyl)ethane
8%
Self-Medication
8%
Antiinfective Agent
8%
Colorectal Carcinoma
8%
IC50
8%
Prevalence
8%
Hemoglobin A1c
7%
Benzoic Acid Derivative
6%
Malignant Neoplasm
6%
Polypharmacy
6%
Comorbidity
6%
Infection
6%
Iron
6%
Tablet
5%
Proton Pump Inhibitor
5%
Quantitative Structure-Activity Relationship
5%
Brain Ischemia
5%
Pharmacotherapy
5%
Respiratory Tract Infection
5%
